Aurora Cannabis (ACB) has announced today the company’s extended pastille offerings in Australia. This expansion marks another meaningful step in Aurora’s deep commitment to offering patients a diverse range of high-quality, premium medical cannabis products to meet their various needs and interests.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACB:
- Aurora Cannabis Enhances Access to Medical Cannabis in Australia
- Aurora Cannabis (ACB) Trades at a Discount Despite Record-Breaking Quarter
- Aurora Cannabis Secures Strategic $27 Million Supply Agreement with SNDL
- Aurora Cannabis announces supply agreement with SNDL
- Aurora Cannabis Shines: Earnings Call Highlights